Literature DB >> 30089692

Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity.

Wenjuan Du1, Meiling Dai1, Zeshi Li2, Geert-Jan Boons2, Ben Peeters3, Frank J M van Kuppeveld1, Erik de Vries1, Cornelis A M de Haan4.   

Abstract

The influenza A virus (IAV) neuraminidase (NA) protein plays an essential role in the release of virus particles from cells and decoy receptors. The NA enzymatic activity presumably needs to match the activity of the IAV hemagglutinin (HA) attachment protein and the host sialic acid (SIA) receptor repertoire. We analyzed the enzymatic activities of N1 NA proteins derived from avian (H5N1) and human (H1N1) IAVs and analyzed the role of the second SIA-binding site, located adjacent to the conserved catalytic site, therein. SIA contact residues in the second SIA-binding site of NA are highly conserved in avian, but not human, IAVs. All N1 proteins preferred cleaving α2,3- over α2,6-linked SIAs even when their corresponding HA proteins displayed a strict preference for α2,6-linked SIAs, indicating that the specificity of the NA protein does not need to fully match that of the corresponding HA protein. NA activity was affected by substitutions in the second SIA-binding site that are observed in avian and human IAVs, at least when multivalent rather than monovalent substrates were used. These mutations included both SIA contact residues and residues that do not directly interact with SIA in all three loops of the second SIA-binding site. Substrate binding via the second SIA-binding site enhanced the catalytic activity of N1. Mutation of the second SIA-binding site was also shown to affect virus replication in vitro Our results indicate an important role for the N1 second SIA-binding site in binding to and cleavage of multivalent substrates.IMPORTANCE Avian and human influenza A viruses (IAVs) preferentially bind α2,3- and α2,6-linked sialic acids (SIAs), respectively. A functional balance between the hemagglutinin (HA) attachment and neuraminidase (NA) proteins is thought to be important for host tropism. What this balance entails at the molecular level is, however, not well understood. We now show that N1 proteins of both avian and human viruses prefer cleaving avian- over human-type receptors although human viruses were relatively better in cleavage of the human-type receptors. In addition, we show that substitutions at different positions in the second SIA-binding site found in NA proteins of human IAVs have a profound effect on binding and cleavage of multivalent, but not monovalent, receptors and affect virus replication. Our results indicate that the HA-NA balance can be tuned via modification of substrate binding via this site and suggest an important role of the second SIA-binding site in host tropism.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  influenza A virus; neuraminidase; second SIA-binding site; sialic acid

Mesh:

Substances:

Year:  2018        PMID: 30089692      PMCID: PMC6158415          DOI: 10.1128/JVI.01243-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Characterization of sialidase from an influenza A (H3N2) virus strain: kinetic parameters and substrate specificity.

Authors:  José França de Barros; Daniela Sales Alviano; Maria Helena da Silva; Marcia Dutra Wigg; Celuta Sales Alviano; Roland Schauer; José Nelson dos Santos Silva Couceiro
Journal:  Intervirology       Date:  2003       Impact factor: 1.763

2.  Identification of Residues That Affect Oligomerization and/or Enzymatic Activity of Influenza Virus H5N1 Neuraminidase Proteins.

Authors:  Meiling Dai; Hongbo Guo; Jos C F M Dortmans; Jojanneke Dekkers; Johan Nordholm; Robert Daniels; Frank J M van Kuppeveld; Erik de Vries; Cornelis A M de Haan
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

3.  Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.

Authors:  Lianlian Jiang; Giovanna Fantoni; Laura Couzens; Jin Gao; Ewan Plant; Zhiping Ye; Maryna C Eichelberger; Hongquan Wan
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

4.  Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein.

Authors:  Wentao Li; Ruben J G Hulswit; Ivy Widjaja; V Stalin Raj; Ryan McBride; Wenjie Peng; W Widagdo; M Alejandra Tortorici; Brenda van Dieren; Yifei Lang; Jan W M van Lent; James C Paulson; Cornelis A M de Haan; Raoul J de Groot; Frank J M van Kuppeveld; Bart L Haagmans; Berend-Jan Bosch
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

5.  Development of a pharmaceutical apotransferrin product for iron binding therapy.

Authors:  L von Bonsdorff; H Tölö; E Lindeberg; T Nyman; A Harju; J Parkkinen
Journal:  Biologicals       Date:  2001-03       Impact factor: 1.856

6.  Eight-plasmid system for rapid generation of influenza virus vaccines.

Authors:  Erich Hoffmann; Scott Krauss; Daniel Perez; Richard Webby; Robert G Webster
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

7.  Entry of influenza A Virus with a α2,6-linked sialic acid binding preference requires host fibronectin.

Authors:  Horasis S Y Leung; Olive T W Li; Renee W Y Chan; Michael C W Chan; John M Nicholls; Leo L M Poon
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

Review 8.  Influenza neuraminidase.

Authors:  Gillian M Air
Journal:  Influenza Other Respir Viruses       Date:  2011-11-16       Impact factor: 4.380

9.  Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.

Authors:  Teddy John Wohlbold; Raffael Nachbagauer; Haoming Xu; Gene S Tan; Ariana Hirsh; Karl A Brokstad; Rebecca J Cox; Peter Palese; Florian Krammer
Journal:  mBio       Date:  2015-03-10       Impact factor: 7.867

10.  The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.

Authors:  W P Burmeister; R W Ruigrok; S Cusack
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

View more
  9 in total

1.  Influenza A Virus Neuraminidase Inhibitors.

Authors:  Nongluk Sriwilaijaroen; Christopher J Vavricka; Hiromasa Kiyota; Yasuo Suzuki
Journal:  Methods Mol Biol       Date:  2022

2.  Multiscale Simulations Examining Glycan Shield Effects on Drug Binding to Influenza Neuraminidase.

Authors:  Christian Seitz; Lorenzo Casalino; Robert Konecny; Gary Huber; Rommie E Amaro; J Andrew McCammon
Journal:  Biophys J       Date:  2020-10-31       Impact factor: 4.033

3.  Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics.

Authors:  Meiling Dai; Wenjuan Du; Carles Martínez-Romero; Tim Leenders; Tom Wennekes; Guus F Rimmelzwaan; Frank J M van Kuppeveld; Ron A M Fouchier; Adolfo Garcia-Sastre; Erik de Vries; Cornelis A M de Haan
Journal:  mBio       Date:  2021-05-11       Impact factor: 7.867

4.  The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance.

Authors:  Wenjuan Du; Hongbo Guo; Vera S Nijman; Jennifer Doedt; Erhard van der Vries; Joline van der Lee; Zeshi Li; Geert-Jan Boons; Frank J M van Kuppeveld; Erik de Vries; Mikhail Matrosovich; Cornelis A M de Haan
Journal:  PLoS Pathog       Date:  2019-06-10       Impact factor: 6.823

5.  Preventing Influenza A Virus Infection by Mixed Inhibition of Neuraminidase and Hemagglutinin by Divalent Inhibitors.

Authors:  Xuan Wei; Wenjuan Du; Margherita Duca; Guangyun Yu; Erik de Vries; Cornelis A M de Haan; Roland J Pieters
Journal:  J Med Chem       Date:  2022-05-12       Impact factor: 8.039

6.  Neuraminidase (NA) 370-Loop Mutations of the 2009 Pandemic H1N1 Viruses Affect NA Enzyme Activity, Hemagglutination Titer, Mouse Virulence, and Inactivated-Virus Immunogenicity.

Authors:  Ting-Hsuan Chen; Chung-Chu Chen; Suh-Chin Wu
Journal:  Viruses       Date:  2022-06-14       Impact factor: 5.818

7.  Binding mechanism of oseltamivir and influenza neuraminidase suggests perspectives for the design of new anti-influenza drugs.

Authors:  Jiaye Tao; Heping Wang; Wenjian Wang; Na Mi; Wei Zhang; Qiujia Wen; Jiajing Ouyang; Xinyun Liang; Min Chen; Wentao Guo; Guoming Li; Jun Liu; Hanning Zhao; Xin Wang; Xuemeng Li; Shengjun Feng; Xinguang Liu; Zhiwei He; Zuguo Zhao
Journal:  PLoS Comput Biol       Date:  2022-07-28       Impact factor: 4.779

8.  Human-type sialic acid receptors contribute to avian influenza A virus binding and entry by hetero-multivalent interactions.

Authors:  Mengying Liu; Liane Z X Huang; Anthony A Smits; Christian Büll; Yoshiki Narimatsu; Frank J M van Kuppeveld; Henrik Clausen; Cornelis A M de Haan; Erik de Vries
Journal:  Nat Commun       Date:  2022-07-13       Impact factor: 17.694

Review 9.  Influenza A Virus Hemagglutinin-Neuraminidase-Receptor Balance: Preserving Virus Motility.

Authors:  Erik de Vries; Wenjuan Du; Hongbo Guo; Cornelis A M de Haan
Journal:  Trends Microbiol       Date:  2019-10-17       Impact factor: 17.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.